The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2026

Filed:

Jul. 24, 2019
Applicant:

Bio-on S.p.a., San Giorgio di Piano, IT;

Inventors:

Maria Pina Mollica, Naples, IT;

Paolo Saettone, San Giorgio di Piano, IT;

Giovanna Trinchese, Naples, IT;

Gina Cavaliere, Naples, IT;

Giuseppina Mattace Raso, Naples, IT;

Mauro Comes Franchini, San Giorgio di Piano, IT;

Assignee:

BIO ON S.P.A., Turin, IT;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/765 (2006.01); A61K 9/00 (2006.01); A61P 3/04 (2006.01); C08G 63/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/765 (2013.01); A61K 9/0053 (2013.01); A61P 3/04 (2018.01); C08G 63/06 (2013.01);
Abstract

A polyhydroxyalkanoate (PHA) containing monomer units of 3-hydroxybutyrate for use, by oral administration, in the prevention or treatment of an overweight or obesity condition, or of metabolic dysfunctions related to the condition. A marked effect was observed on the reduction of the body weight, both in the case of a standard diet and in the case of a diet rich in fats, a reduction that can be attributed to an increase in lipid oxidation to the detriment of the deposit of excess lipids, as confirmed by the decrease in the body weight and by analyses of the body composition. A positive effect on the metabolic dysfunctions related to an overweight or obesity condition has also been verified, in particular on dyslipidemias, such as the blood level of low-density lipoproteins (LDL cholesterol) and triglycerides, as well as an improvement in the inflammatory state.


Find Patent Forward Citations

Mollica, Maria. (2026). Polyhydroxyalkanoates for use in the prevention or treatment of an overweight or obesity condition, or of metabolic dysfunctions related to said condition (U.S. Patent No. 12558372). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12558372

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…